Prime Medicine (PRME) Retained Earnings (2021 - 2026)
Prime Medicine (PRME) reported Retained Earnings of -$1000.0 for Q1 2026, up 100.0% on a YoY basis from -$500.0 in Q1 2025, and down 101.22% quarter-over-quarter from $82000.0 in Q4 2025.
Prime Medicine (PRME) Retained Earnings (2021 - 2026) Analysis & Trends
Prime Medicine has reported Retained Earnings for 6 years, with the latest figure at -$1000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 100.0% year-over-year to -$1000.0; the trailing twelve-month figure through Mar 2026 stood at -$1000.0 (up 100.0% YoY), and the FY2025 full-year result was $82000.0, up 8100.0% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1000.0, down from $82000.0 in the prior quarter.
- The five-year high for Retained Earnings was $82000.0 in Q4 2025, with the low at -$842.3 million in Q3 2025.
- Historically, Retained Earnings has averaged -$312.6 million across 5 years, with a median of -$253.9 million in 2022.
- The largest YoY upside for Retained Earnings was 8100.0% in 2025 against a maximum downside of 777900.0% in 2025.
- Prime Medicine's Retained Earnings stood at -$384000.0 in 2022, then plunged by 127850.52% to -$491.3 million in 2023, then soared by 100.0% to $1000.0 in 2024, then jumped by 8100.0% to $82000.0 in 2025, then tumbled by 101.22% to -$1000.0 in 2026.
- The last three Retained Earnings figures came in at -$1000.0 (Q1 2026), $82000.0 (Q4 2025), and -$842.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Prime Medicine | 572.02 Mn | 572.02 Mn | - | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | 82,000.00 |
| Sep 30, 2025 | -842.30 Mn |
| Jun 30, 2025 | -791.70 Mn |
| Mar 31, 2025 | -739.10 Mn |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | -644.94 Mn |
| Jun 30, 2024 | -592.42 Mn |
| Mar 31, 2024 | -95,000.00 |
| Dec 31, 2023 | -491.33 Mn |
| Sep 30, 2023 | -149,000.00 |
| Jun 30, 2023 | -268,000.00 |
| Mar 31, 2023 | -332.60 Mn |
| Dec 31, 2022 | -384,000.00 |
| Sep 30, 2022 | -253.91 Mn |
| Dec 31, 2021 | -171.38 Mn |